Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis

Detalles Bibliográficos
Autores principales:	Taylor, P, Takeuchi, T, Burmester, G, Durez, P, Smolen, J, Deberdt, W, Zhong, J, Teres, JR, Bello, N, Winthrop, K, Pope, J
Formato:	Conference item
Lenguaje:	English
Publicado:	Journal of Rheumatology 2022

Ejemplares similares